Steve Allsop Director National Drug Research Institute Preventing - - PowerPoint PPT Presentation

steve allsop
SMART_READER_LITE
LIVE PREVIEW

Steve Allsop Director National Drug Research Institute Preventing - - PowerPoint PPT Presentation

National Drug Research Institute Preve event nting ing Harmful Drug Use in Austral ralia ia Steve Allsop Director National Drug Research Institute Preventing and responding to drug problems: where does the evidence take us? www.ndri


slide-1
SLIDE 1

www. www.ndri dri.curtin .curtin.edu.au .edu.au

National Drug Research Institute

Preve event nting ing Harmful Drug Use in Austral ralia ia

Steve Allsop

Director National Drug Research Institute

Preventing and responding to drug problems: where does the evidence take us?

slide-2
SLIDE 2

NDSHS: Summary of recent drug use: proportion of the population aged 14 years, 1993 to 2007

Source: Australian Institute of Health and Welfare, (2008). 2007 National Drug Strategy Household Survey: detailed findings. Drug Statistics Series No. 22. Cat no. PHE 107. Canberra: Australian Institute of Health and Welfare. p. 4.

slide-3
SLIDE 3

Some background comments

  • Is drug use getting worse?

– It ain‟t necessarily so, but a mixed picture

  • Tobacco
  • Cannabis
  • Amphetamine
  • Alcohol
  • Ecstasy
  • Pharmaceuticals
  • Cocaine
  • “Research chemicals”
  • Heroin
slide-4
SLIDE 4

Last Drug Injected

slide-5
SLIDE 5

Some background comments

  • Overall apparent changes may hide some

important information

– Estimates of alcohol consumption have been underestimates – Heavier use among some people (some young people; some Indigenous communities) – Patterns/frequency of use among some – Specific risks of early onset use

slide-6
SLIDE 6

We need to better communicate & respond to the complexity of drug use and related harm

slide-7
SLIDE 7

What causes drug use and drug problems?

  • Drug use, drug related harm and

dependence emerge from risk factors and protective factors and the relationship amongst these

slide-8
SLIDE 8

Risk factors

  • Individual factors
  • Genetic characteristics and vulnerabilities - Sensation/novelty seeking
  • Poor problem solving
  • Self-esteem and alienation
  • Family factors
  • Favourable attitudes to drug use/drinking/ poor supervision and monitoring
  • Family disharmony, conflict, violence, abuse and/or neglect
  • Life events
  • Trauma
  • Community factors
  • Poor housing and economic circumstances; deviant peers
  • Poor connectedness
  • Availability
  • Actual and perceived
slide-9
SLIDE 9

Protective factors

  • Quality family life – harmony, support
  • Connectedness and sense of belonging
  • School

– Social and academic competence

  • Adults
  • Community
  • “Spiritual”, not just material
slide-10
SLIDE 10

PLUS

  • The fact that some people like to take

risks, enjoy the effects etc etc

slide-11
SLIDE 11

How do our more popular interventions fit with these observations?

slide-12
SLIDE 12

When will we learn- What doesn’t work?

  • Avoid making it worse
slide-13
SLIDE 13
slide-14
SLIDE 14

What doesn’t work?

  • Making it worse
  • Reliance on „masterstrokes‟/magic bullet

– Singular punitive approaches – Singular psycho/social/biological approaches – Moral persuasion – Education as propaganda – „show them the dangers and they won‟t do it‟

slide-15
SLIDE 15

What works?

  • Reduce known risk factors

– (e.g. access to alcohol; supporting vulnerable families) and

  • Encourage known protective factors

– (e.g. connectedness to schools etc)

  • Target interventions to groups or contexts known

to have high level risk factors (e.g. particular work contexts; certain entertainment settings)

  • Delay onset of use and heavy use
slide-16
SLIDE 16

What works?

  • Universal interventions for alcohol and tobacco

(e.g. taxation policy)

  • Law enforcement influence on shaping patterns
  • f illicit drug use and hazardous supply of licits
  • Targeted interventions to high risk contexts and

some disadvantaged populations (e.g. school engagement for at-risk children; vulnerable families interventions)

  • Brief and opportunistic interventions, treatment,

and harm reduction strategies

slide-17
SLIDE 17

But many of our interventions are still inaccessible for many

slide-18
SLIDE 18

We need to re-invest in harm minimisation

slide-19
SLIDE 19

Harm minimisation

  • RBT
  • Thiamine enrichment
  • Managing school leavers
  • Intelligence about particularly harmful drug

formulations

  • Enforcing laws about not smoking in cars with

children?

  • Enforcing liquor licensing legislation
  • Avoiding compromising NSP programs
slide-20
SLIDE 20

Bring the community onside

slide-21
SLIDE 21

Bring the community onside

  • How community perceives issue(s) matters

– e.g. models of drug use/dependence – Marginalisation vs humanisation of consumers

  • May tolerate impersonal distal outcomes of drug use

(e.g. alcohol causes cirrhosis for some people) but less willing to tolerate more immediate outcomes that have personal relevance (alcohol intoxication puts me at risk)

  • If we wish to engage communities:

– How drug use has personal relevance – How cost-efficient interventions have personal and community wide benefits – It is possible to act and things will improve

slide-22
SLIDE 22

Seriously invest in the development

  • f integrated services
  • Many of the factors that predict risk of

hazardous drug use also predicts a range

  • f other problems (e.g. CD; MH probs. etc)

– Avoid fragmented responses

slide-23
SLIDE 23

Seriously invest in the development

  • f integrated services
  • Many of the factors that predict risk of

hazardous drug use also predicts a range

  • f other problems (e.g. CD; MH probs. etc)

– Avoid fragmented responses

  • But feature of many of our services is

disaggregated funding, performance indicators, management, physical location, hours of service

– e.g. management of ATS intoxication

slide-24
SLIDE 24

What new challenges should we anticipate?

  • Changing patterns of alcohol use

– Significant proportion of young Australians who are drinking at risky to very risky levels

  • Increases in hospitalisations and emergency

departments

  • Increases in longer term adverse health outcomes

– E.g. cirrhosis; prostate cancer; breast cancer?

  • Increases in costs to public amenity and safety?
  • Increases in combined ATS and alcohol use?
slide-25
SLIDE 25

What new challenges should we anticipate?

  • The challenges and opportunities of new

technologies

– Information and misinformation/poor information about drugs – Purchasing drugs over the internet and across borders

  • Confusion about legality
  • The emergence of smaller distribution networks

– Opportunity to inform and provide interventions

slide-26
SLIDE 26

What new challenges should we anticipate?

  • The development and marketing of

“research chemicals”

– Rapid changes in patterns of use – Unclear risk profile – Confusion about safety/risk/legality – New challenges for law enforcement and health services

slide-27
SLIDE 27

What new challenges should we anticipate?

  • Increased numbers of children raised by

parents with alcohol/other drug problems

– Disadvantaged biology/increased genetic vulnerability – Disadvantaged environments – Increased risks – Inter-generational risky drug use

– Note quality of parenting/home environment important determinant of risk irrespective of drug use

slide-28
SLIDE 28

What new challenges should we anticipate?

  • Ageing population

– Consumers of illicit drugs - Cohorts ageing, creating new clinical challenges – Population increasing – without any other changes, creates significant public health challenge – Drinking and drug use histories of current older population distinct from those who will be over 65 in 10-20 years – There is evidence of change - increasing size of population who are drinking/using drugs at hazardous levels

slide-29
SLIDE 29

What challenges should we meet?

  • The comparatively poor investment in prevention

– Short term – Sporadic – Not linked to mainstream strategies that are effective

  • The predictors of hazardous drug use are predictors of a

range of adverse health/social outcomes

– e.g. academic and social competence; CD; family functioning

  • Yet most prevention strategies are drug specific
slide-30
SLIDE 30

What challenges should we meet?

My wish list in short term

  • Address:

– the increasing availability of alcohol – better resourcing of responses to co-existing mental health and drug problems – the needs of Indigenous communities where things are probably getting worse, not better

  • Invest in interventions within the criminal

justice system

slide-31
SLIDE 31

What challenges should we meet?

My wish list in short term

  • Respond to the needs of the vast majority of

people affected by drug use who do not come into contact with our services, or have a tenuous link with them

slide-32
SLIDE 32

What challenges should we meet?

My wish list in short term

  • Respond to the needs of the vast majority of

people affected by drug use who do not come into contact with our services, or have a tenuous link with them

  • Challenge the marginalisation of consumers

– Reduced resources and service provision – Reluctance to seek help

  • Challenge the misunderstanding and

demonisation of harm reduction

slide-33
SLIDE 33

What challenges should we meet?

My wish list in short term

  • Respond to the needs of the vast majority of

people affected by drug use who do not come into contact with our services, or have a tenuous link with them

  • Challenge the marginalisation of consumers

– Reduced resources and service provision – Reluctance to seek help

  • Challenge the misunderstanding and

demonisation of harm reduction

  • Speak with a louder more coordinated voice
slide-34
SLIDE 34

Steve Allsop National Drug Research Institute s.allsop@curtin.edu.au www.ndri.curtin.edu.au